Clinical Research Studies On The Efficacy Of TestofenThe majority of testosterone boosting supplements on the market contain Testofen ingredients. This ingredient is a standardized fenugreek extract, which has been used for centuries as a traditional medicine. The extract comes with almost 100 natural substances that can treat dozens of conditions. Fenugreek is also known to provide effective treatment for conditions, such as high cholesterol, stomach discomfort and more.
A number of studies have linked some of the extract's chemicals to an increase in testosterone. The chemicals are called saponins and they are active components in Testofen. The ingredient is safe for use and provides a viable way to boost overall vitality. It has been proven to support muscle mass gains and contributes to fat loss while stimulating free testosterone production.
Testofen is a unique extract of fenugreek capable of reducing symptoms of andropause in men in addition to supporting healthy sexual desire. Combing balanced diets with regular exercise and supplements containing Testofen is a sure-fire way to maintain healthy levels of free testosterone.
Fenugreek can control glucose levels. For this reason, the extract is used by diabetics on a regular basis. The ingredient lowers inflammation when combined with curcumin and cinnamon.
A number of placebo controlled human clinical trials have been conducted with the aim to verify the efficacy of Testofen substance. The majority of results showed a marked increase in the secretion of free testosterone by almost 100 percent in comparison to participants who received a placebo.
The ingredient also showed the capacity to prevent muscle breakdown following intense workouts. In addition, it provides a practical way to regulate blood urea nitrogen (BUN) levels. Fat loss is one of the key benefits of supplementing with products containing Testofen. A separate study revealed that Fenugreek can enhance the absorption of creatine into the system.
According to a report published by the US National Library of Medicine (NLM) Fenugreek enhances the physiological aspects of male libido. The standardized mineral formulation and trigonella foenum-graecum extract (Fenugreek) showed its efficacy in a double blind randomized placebo controlled study.
The clinical trial involved up to 60 healthy males of ages ranging from 25 to 52. All the test subjects were randomized to an oral dose consisting two tablets per day and none suffered from erectile dysfunction. The placebo or active treatment lasted for six weeks.
Researchers evaluated the results using up to four domain scores and the self-administered QOL total score (DISF-SR). These parameters were considered the primary outcome measure while specific quality of life factors became the secondary outcome. Overall, testofen showed a marked positive effect on physiological aspects of male libido.
The results demonstrated a notable increase in the sub-domains of orgasm and sexual arousal. The self-reported satisfaction levels were also significantly high when it comes to energy and well-being. However, the participants did not notice any effect on mood and sleep.
Meanwhile, testosterone and serum prolactin stayed within the reference range. This proves that it has the capacity to maintain healthy levels of testosterone in the body.
In relation to clinical research trials conducted on animals, a study carries out in 2010 on rats demonstrated that Testofen levels can elevate the weight of ani-levator muscle. In turn, these changes support both body weight and muscle mass.
Human study on Andropause (male menopause)
A placebo-controlled clinical study aimed at evaluating the effectiveness of Testofen on the symptoms of Andropause was conducted in Australia. The clinical trial lasted for 12 weeks and involved 120 males of ages ranging from 40 to 75. All the participants had symptoms of Andropause and were still healthy.
The researchers evaluated the male subjects using clinically validated questionnaires. The AMS forms featured 17 questions covering three key domains, including sexual, psychological and somatic. The questionnaires provided an easy way to determine the acuteness of the Andropause symptoms. In addition, the researchers used the DISF-SR to measure the listed parameters.
The results of the placebo-controlled clinical study showed a significant reduction of Andropause symptoms in the active group using Testofen. The improvements were recorded between week 6 and 12. The reduction was noted in all sub-domains with the exception of psychological sub-score. The participants enjoyed a vastly improved sexual health. The improvements were characterized by elevated levels of sexual desire, total testosterone levels and sexual activity.